AR013479A1 - Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales. - Google Patents
Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales.Info
- Publication number
- AR013479A1 AR013479A1 ARP980104483A ARP980104483A AR013479A1 AR 013479 A1 AR013479 A1 AR 013479A1 AR P980104483 A ARP980104483 A AR P980104483A AR P980104483 A ARP980104483 A AR P980104483A AR 013479 A1 AR013479 A1 AR 013479A1
- Authority
- AR
- Argentina
- Prior art keywords
- agonists
- bone volume
- increase bone
- natural selective
- natural
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- 229940127293 prostanoid Drugs 0.000 title 1
- 150000003814 prostanoids Chemical class 0.000 title 1
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para aumentar el volumen oseo que comprende la administracion de un agosnista FP selectivo no natural a un sujeto que necesita dicho tratamiento.La presente invencion se refiere, además, a un método para el tratamiento o prevencion de desordenes oseos que comprende la administracion de un agonistaFP selectivo no natural a un sujeto que necesita dicho tratamiento.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5830697P | 1997-09-09 | 1997-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013479A1 true AR013479A1 (es) | 2000-12-27 |
Family
ID=22015996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104483A AR013479A1 (es) | 1997-09-09 | 1998-09-08 | Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6156799A (es) |
| EP (1) | EP1045694A1 (es) |
| JP (1) | JP2001515864A (es) |
| KR (1) | KR20010023840A (es) |
| CN (1) | CN1269721A (es) |
| AR (1) | AR013479A1 (es) |
| AU (1) | AU739275B2 (es) |
| BR (1) | BR9811780A (es) |
| CA (1) | CA2303800A1 (es) |
| CO (1) | CO4980882A1 (es) |
| HU (1) | HUP0004581A2 (es) |
| ID (1) | ID24827A (es) |
| IL (1) | IL134760A0 (es) |
| NO (1) | NO20001171L (es) |
| PE (1) | PE119099A1 (es) |
| PL (1) | PL339288A1 (es) |
| SK (1) | SK3412000A3 (es) |
| TR (1) | TR200000662T2 (es) |
| WO (1) | WO1999012551A1 (es) |
| ZA (1) | ZA988228B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3711900A (en) * | 1999-03-05 | 2000-09-21 | Procter & Gamble Company, The | Method of increasing bone volume using non-naturally-occurring ep1 selective agonists |
| ES2232434T3 (es) | 1999-03-05 | 2005-06-01 | Duke University | Analogos de prostaglandinas c-16 fp selectivas insaturadas. |
| WO2000051616A1 (en) * | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | Method of increasing bone volume using non-naturally-occurring selective fp agonist and dito ep1 agonist prostaglandin derivatives |
| IL145123A0 (en) * | 1999-03-05 | 2002-06-30 | Procter & Gamble | C16 unsaturated fp-selective prostaglandin analogs |
| CA2303060A1 (en) * | 1999-04-14 | 2000-10-14 | United States Gear Corporation | Towed vehicle brake controller |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US6904123B2 (en) | 2000-08-29 | 2005-06-07 | Imaging Therapeutics, Inc. | Methods and devices for quantitative analysis of x-ray images |
| EP1365684A2 (en) | 2000-08-29 | 2003-12-03 | Imaging Therapeutics | Methods and devices for quantitative analysis of x-ray images |
| US7467892B2 (en) | 2000-08-29 | 2008-12-23 | Imaging Therapeutics, Inc. | Calibration devices and methods of use thereof |
| US7660453B2 (en) | 2000-10-11 | 2010-02-09 | Imaging Therapeutics, Inc. | Methods and devices for analysis of x-ray images |
| US8639009B2 (en) | 2000-10-11 | 2014-01-28 | Imatx, Inc. | Methods and devices for evaluating and treating a bone condition based on x-ray image analysis |
| ATE440536T1 (de) | 2001-05-25 | 2009-09-15 | Imaging Therapeutics Inc | Verfahren zur diagnose, behandlung und prävention von knochenverlust |
| CN1893977B (zh) * | 2001-07-23 | 2012-12-05 | 小野药品工业株式会社 | 以ep4激动剂为活性成分的治疗与骨质损失有关的疾病的药物 |
| US7608637B2 (en) * | 2001-07-23 | 2009-10-27 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient |
| US20060013851A1 (en) * | 2002-02-07 | 2006-01-19 | Giroux Karen J | Therapeutic polyanhydride compounds for drug delivery |
| US8965075B2 (en) | 2002-09-16 | 2015-02-24 | Imatx, Inc. | System and method for predicting future fractures |
| US7840247B2 (en) | 2002-09-16 | 2010-11-23 | Imatx, Inc. | Methods of predicting musculoskeletal disease |
| JP2007524438A (ja) | 2003-03-25 | 2007-08-30 | イメージング セラピューティクス，インコーポレーテッド | 放射線画像処理技術における補償の方法 |
| CA2539487A1 (en) * | 2003-09-19 | 2005-03-31 | Imaging Therapeutics, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| US8290564B2 (en) | 2003-09-19 | 2012-10-16 | Imatx, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| EP1789924A2 (en) | 2004-09-16 | 2007-05-30 | Imaging Therapeutics, Inc. | System and method of predicting future fractures |
| WO2008034101A2 (en) * | 2006-09-15 | 2008-03-20 | Imaging Therapeutics, Inc. | Method and system for providing fracture/no fracture classification |
| US8939917B2 (en) | 2009-02-13 | 2015-01-27 | Imatx, Inc. | Methods and devices for quantitative analysis of bone and cartilage |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4621100A (en) * | 1981-09-25 | 1986-11-04 | The Upjohn Company | Treatment of osteoporosis with prostaglandins |
| AU3607293A (en) * | 1992-02-05 | 1993-09-03 | Merck & Co., Inc. | Implant therapy for bone growth stimulation |
| US5310759A (en) * | 1992-08-12 | 1994-05-10 | Bockman Richard S | Methods of protecting and preserving connective and support tissues |
| US5409911A (en) * | 1992-09-11 | 1995-04-25 | Merck & Co., Inc. | Prostaglandin analog for treating osteoporosis |
| US5747660A (en) * | 1995-11-06 | 1998-05-05 | The University Of Colorado | Nucleic acid encoding prostaglandin F2α receptor regulatory protein |
| US5703108A (en) * | 1996-02-28 | 1997-12-30 | Pfizer Inc. | Bone deposition by certain prostaglandin agonists |
-
1998
- 1998-09-04 HU HU0004581A patent/HUP0004581A2/hu unknown
- 1998-09-04 ID IDW20000637A patent/ID24827A/id unknown
- 1998-09-04 EP EP98944718A patent/EP1045694A1/en not_active Withdrawn
- 1998-09-04 IL IL13476098A patent/IL134760A0/xx unknown
- 1998-09-04 PL PL98339288A patent/PL339288A1/xx unknown
- 1998-09-04 JP JP2000510448A patent/JP2001515864A/ja not_active Withdrawn
- 1998-09-04 KR KR1020007002516A patent/KR20010023840A/ko not_active Ceased
- 1998-09-04 US US09/148,105 patent/US6156799A/en not_active Expired - Fee Related
- 1998-09-04 TR TR2000/00662T patent/TR200000662T2/xx unknown
- 1998-09-04 CN CN98808885A patent/CN1269721A/zh active Pending
- 1998-09-04 WO PCT/US1998/018338 patent/WO1999012551A1/en not_active Ceased
- 1998-09-04 SK SK341-2000A patent/SK3412000A3/sk unknown
- 1998-09-04 AU AU92192/98A patent/AU739275B2/en not_active Ceased
- 1998-09-04 CA CA002303800A patent/CA2303800A1/en not_active Abandoned
- 1998-09-04 BR BR9811780-7A patent/BR9811780A/pt not_active IP Right Cessation
- 1998-09-08 AR ARP980104483A patent/AR013479A1/es unknown
- 1998-09-09 CO CO98051811A patent/CO4980882A1/es unknown
- 1998-09-09 PE PE1998000854A patent/PE119099A1/es not_active Application Discontinuation
- 1998-09-09 ZA ZA988228A patent/ZA988228B/xx unknown
-
2000
- 2000-03-07 NO NO20001171A patent/NO20001171L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0004581A2 (hu) | 2001-05-28 |
| AU739275B2 (en) | 2001-10-11 |
| BR9811780A (pt) | 2000-09-12 |
| JP2001515864A (ja) | 2001-09-25 |
| US6156799A (en) | 2000-12-05 |
| PE119099A1 (es) | 2000-02-03 |
| AU9219298A (en) | 1999-03-29 |
| KR20010023840A (ko) | 2001-03-26 |
| IL134760A0 (en) | 2001-04-30 |
| CA2303800A1 (en) | 1999-03-18 |
| NO20001171L (no) | 2000-05-09 |
| TR200000662T2 (tr) | 2000-07-21 |
| NO20001171D0 (no) | 2000-03-07 |
| CO4980882A1 (es) | 2000-11-27 |
| CN1269721A (zh) | 2000-10-11 |
| SK3412000A3 (en) | 2000-12-11 |
| PL339288A1 (en) | 2000-12-04 |
| ID24827A (id) | 2000-08-24 |
| EP1045694A1 (en) | 2000-10-25 |
| ZA988228B (en) | 1999-03-09 |
| WO1999012551A1 (en) | 1999-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013479A1 (es) | Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales. | |
| PA8484301A1 (es) | Formulaciones farmaceuticas de liberacion controlada | |
| GT199800037A (es) | Combinaciones para diabetes de sulfonilurea - glitazona. | |
| DK0777483T3 (da) | Fremgangsmåder og middel til lægemiddelindgivelse | |
| PT831882E (pt) | Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| SV1995000007A (es) | Derivados del acido micofenolico 5-substituidos. | |
| ES2164842T3 (es) | Procedimiento para la preparacion de composiciones de microcapsulas. | |
| BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
| IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
| NZ314839A (en) | 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues | |
| AU1565300A (en) | Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol | |
| PA8452701A1 (es) | Agonistas de prostaglandinas | |
| DK1040119T3 (da) | Hemiasterlinanaloger | |
| MY122877A (en) | Composition. | |
| DK1420827T3 (da) | 5-CNAC sp, oralt indgivelsesmiddel for parathyroidhormonfragmenter | |
| BR9911917A (pt) | Composições compreendendo análogos de gaba e cafeìna | |
| MX9703944A (es) | Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis. | |
| BR0011174A (pt) | Composições, compostos, compostos isolados e métodos para controlar pestes | |
| FR2684543B1 (fr) | Ligament artificiel, notamment pour la cheville. | |
| BG105275A (en) | Tan-1057 derivatives | |
| ES2174196T3 (es) | Utilizacion de ceramida para el tratamiento de las uñas. | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| AR012465A1 (es) | Sistema de implante dental que tiene estabilidad mejorada | |
| GT199900062A (es) | Preparados efervescentes. |